Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surface markers in leukemias and lymphomas.

F P Siegal, D A Filippa, B Koziner

    The American Journal of Pathology
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recombinant Interferon Alpha-2b in Patients with Progressive and/or Recurrent Hodgkin's Disease.

    Leukemia & lymphoma·2016
    Same author

    Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    The first Buenos Aires international workshop on cellular and molecular therapies.

    Cytotherapy·2006
    Same author

    CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration.

    Lupus·2003
    Same author

    Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing.

    Scandinavian journal of immunology·2002

    Cell marker analysis deepens understanding of lymphoma biology and normal lymphocyte function. This research benefits immunologists, pathologists, clinicians, and patients, advancing lymphoma and lymphoproliferative disorder study.

    Area of Science:

    • Immunology and Pathology
    • Hematology and Oncology

    Background:

    • Lymphomas are complex diseases requiring advanced diagnostic tools.
    • Understanding normal lymphocyte function is crucial for diagnosing lymphoproliferative disorders.

    Purpose of the Study:

    • To highlight the significance of cell marker analysis in lymphoma research.
    • To underscore the benefits of this analysis for medical professionals and patients.

    Main Methods:

    • Analysis of cell markers in lymphoma and lymphoproliferative disorders.
    • Application of immunological and morphological techniques.

    Main Results:

    • Cell marker analysis has significantly improved the understanding of lymphoma biology and morphology.
    • Insights into normal lymphocyte function have been gained through this approach.

    Related Experiment Videos

    Conclusions:

    • Continued study of cellular differentiation in lymphoproliferative disorders is essential.
    • Cell marker analysis is a valuable tool for advancing lymphoma diagnosis and treatment.